Smartphone enabled upconversion nanoparticle-based lateral flow strip for ultra-low concentration of methamphetamine detection

The combination of upconversion nanoparticles (UCNPs) and Lateral Flow Assays (LFAs) is becoming one of the most desirable quantitative assays for point-of-care testing (POCT) due to their excellent chemical and optical properties, which make them commercially viable as fast, sensitive and portable. We propose upconversion nanoparticle-based lateral flow assays (UCNP-LFAs) combined with computer vision for the instantaneous detection of small molecule targets in a commercial medical device. The device overcomes the traditional lengthy pre-processing and ambiguous qualitative results, where computer vision algorithms improve the sensitivity and robustness of quantitative results. Compared with the standard quantitative testing process, the accuracy of its quantitative test results was improved by 17.4%. The device detected and reported the quantitative results of Methamphetamine (MET) concentration with the lower limit of detection (LOD) of 0.1 ng/ml in 20 s in field tests. Its success demonstrated good sensitivity, repeatability, and robustness. Most importantly, the entire device measures only 100 mm * 120 mm* 74 mm and weighs 351.2 g, combining portability and immediacy and providing quantitative data for small molecule targets at a lower concentration. This makes our system an extraordinarily creative and attractive approach, especially for applications in complex field environments with chaotic personnel and special emergencies.